Expertise in
14
conditions

Chokri Mhiri

CHU Habib Bourguiba
Sfax, TN 
Expertise in
14
conditions
CHU Habib Bourguiba
Sfax, TN 

Overview

Chokri Mhiri practices practicing medicine in Sfax, Tunisia.

Mhiri is highly rated in 14 conditions, according to our data. Their clinical expertise encompasses Paraplegia, Spasticity, Spastic Paraplegia Type 7, and Limb-Girdle Muscular Dystrophy.

They are actively involved in clinical research, co-authoring 84 peer reviewed articles and participating in 2 clinical trials.

Locations

CHU Habib Bourguiba
Sfax, Tunisia
Other Locations
Ferdaous Street, Sfax, 3029, Tunisia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Clinical and Genetic Analysis of Autosomal Recessive Forms of Cerebellar Ataxias and Spastic Paraplegias
Clinical and Genetic Analysis of Autosomal Recessive Forms of Cerebellar Ataxias and Spastic Paraplegias
Enrollment Status: Completed
Publish Date: February 04, 2025
Evaluating the Long-Term Outcomes and Durability of Effect Following Treatment With Cladribine Tablets for MS: An Exploratory Phase IV Ambispective Study of Patients Who Previously Participated in the CLARITY/CLARITY-EXT and ORACLE MS Clinical Trials (CLASSIC-MS)
Evaluating the Long-Term Outcomes and Durability of Effect Following Treatment With Cladribine Tablets for MS: An Exploratory Phase IV Ambispective Study of Patients Who Previously Participated in the CLARITY/CLARITY-EXT and ORACLE MS Clinical Trials (CLASSIC-MS)
Enrollment Status: Completed
Publish Date: October 31, 2023
Intervention Type: Other
Study Drug: Cladribine
Study Phase: Phase 4
View 1 Less Clinical Trial

83 Total Publications

Modified Delphi consensus on the use of cladribine tablets in relapsing-remitting multiple sclerosis in North-West Africa.
Modified Delphi consensus on the use of cladribine tablets in relapsing-remitting multiple sclerosis in North-West Africa.
Journal: Multiple sclerosis and related disorders
Published: April 05, 2026

Frequently Asked Questions about Chokri Mhiri

Is Chokri Mhiri a top-rated expert for Paraplegia?

MediFind is an objective health platform that identifies experts based on real-world data. Chokri Mhiri is classified as an Distinguished expert for Paraplegia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Chokri Mhiri participate in research or clinical trials?

Yes. Chokri Mhiri has published 83 articles and abstracts on conditions like Paraplegia. You can view a list of Chokri Mhiri's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mhiri's expertise for a condition
ConditionClose
    View All 13 Advanced Conditions
    View All 55 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile